Europe In Vitro Diagnostics (IVD) Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 5.50 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe In Vitro Diagnostics (IVD) Market Analysis
The European in-vitro diagnostics market is expected to register a CAGR of 5.5% over the forecast period.
COVID-19 has significantly impacted supply-demand in the in-vitro diagnostics market in Europe as it was one of the severely affected regions. Increased number of in-vitro diagnostics testing for the diagnosis of COVID-19 symptoms augmented the adoption rate of these instruments. For instance, according to a report by the Gov.UK, almost 7.6 million lateral flow device tests were performed between 8 April and 21 April 2021 in England. This high volume of in-vitro diagnostic (IVD) tests in Europe for the precise diagnostics of COVID symptoms augmented the market's growth during the pandemic. However, the market growth remained stable during the post-pandemic period in Europe due to the reduced demand for COVID-19 in-vitro diagnostic testing and decreased confirmed cases in the region.
One of the major factors fueling market growth is the rising prevalence of chronic diseases throughout Europe. An increasing number of patients suffering from chronic diseases, including cancer, cardiovascular diseases, diabetes, and others, is augmenting the demand for early diagnosis. Further, the rising prevalence of several infectious diseases, such as influenza, tuberculosis, hepatitis, and others, is also fueling the demand for in-vitro diagnostics tests. For instance, according to European Centre for Disease Prevention and Control (ECDC), the number of reported influenza cases in Europe was 4,690 in the 2021-2022 season, significantly higher than the previous year. Also, according to data from International Diabetes Federation in 2021, the prevalence of diabetes among adults in Europe in 2021 was 9.2%, which was anticipated to increase to 9.8% by 2030. This increasing patient pool is growing the demand for precise diagnostics techniques, including molecular diagnostics, immunodiagnostics, and others, for specific outcomes, early detection, and reducing the rate of false positives during diagnostic procedures, which drive the demand for advanced in-vitro diagnostics products in Europe.
Further, the launch of advanced point-of-care testing kits for different indications, which are simple to use and highly efficient, is expected to boost the adoption of in-vitro diagnostics products in the region, thereby fuelling growth in the market. For instance, in July 2021, QuantuMDx Group Ltd. launched Q-POC in Europe to offer precise and rapid results for SARS-COV-2 within 30 minutes.
The increasing number of initiatives for the awareness of chronic diseases also increases the demand and adoption rate of in-vitro diagnostics tests for early detection. For instance, in August 2022, NHS organized a lung cancer awareness campaign to increase disease awareness and the importance of early detection through the available diagnostic procedures.
Therefore, owing to the high burden of chronic and infectious diseases, the launch of advanced products, and growing awareness, the demand for in-vitro diagnostics (IVD) products is expected to increase in Europe over the forecast period. However, stringent regulations and cumbersome reimbursement procedures will restrain the market's growth.
Europe In Vitro Diagnostics (IVD) Market Trends
The Instrument Segment is Expected to Hold a Major Share in the Market
In-vitro diagnostics (IVD) instruments are medical devices used to perform tests to detect diseases and infections by examining specimens of bodily substances, such as urine, blood, tissues, and stool. The instrument segment encompasses the apparatus or devices, such as targeted gene sequencing devices, clinical chemistry analyzers, immunology analyzers, and others, which are used alone or in combination, and are intended by the manufacturer for the in-vitro examination of specimens derived from the human body.
Some of the standard IVD instruments include coagulation test systems, blood sugar monitoring systems, slide processing systems, cell imaging & analysis systems, and PCR testing platforms like the Abbott m2000 RealTime System. One of the primary growth drivers of IVD instruments is the increasing application of multi-test media during the diagnostics procedure. In-vitro diagnostic testing can detect multiple markers simultaneously by integrating multi-test platforms. This is particularly advantageous when screening for the presence of drugs in a patient. In addition, the rising acceptance of routine diagnostics among the general population after the pandemic hit is also likely to drive the growth of the instrument segment of the market in Europe over the forecast period.
In addition, the increasing number of diagnostic testing centers in Europe is resulting in higher demand for in-vitro diagnostic instruments, resulting in segmental growth. For instance, according to the Government of the United Kingdom's April 2022 update, about GBP 36 billion will be invested in the health and social care systems over the next three years. Further, per the same source, under the investment initiatives, about 160 community diagnostic centers will be established in England by 2025, of which 73 are already operational. Hence, with the new investments for establishing or expanding diagnostic centers, the demand for IVD instruments is expected to increase in the region.
Additionally, introducing advanced instruments by the major players in Europe supports the higher adoption rate of advanced instrument among healthcare professionals for precisely detecting symptoms associated with several disorders. For instance, in May 2022, Gradientech received the CE-IVD approval for its QuickMIC system to offer ultrarapid antibiotic susceptibility testing for sepsis due to infectious diseases.
Hence, the wide application of in-vitro diagnostic instruments, an increasing number of diagnostic centers, and the introduction of advanced instrument fuel the segment's growth in Europe.
United Kingdom is Expected to have Significant Market Share over the Forecast Period
The in-vitro diagnostics market in the United Kingdom is expected to grow due to the increase in point-of-care (POC) diagnostics tests and the rising prevalence of different chronic diseases in the country. For instance, according to a report updated by Macmillan Cancer Support in October 2022, it was estimated that the number of new cancer cases will reach 3.5 million by 2025 and increase to 4 million by 2030 in the United Kingdom.
Also, according to the International Diabetes Federation (IDF), the number of people diagnosed with diabetes was 3.99 million in 2021, which is anticipated to reach up to 4.14 million by 2030 in the United Kingdom. Thus, the higher prevalence rate of chronic disorders is augmenting the adoption rate of in-vitro diagnostics devices for early diagnosis and supporting market growth.
Furthermore, the healthcare infrastructure development in the United Kingdom is poised to contribute significantly to the country's growth in the overall market. For instance, according to an article by the Department of Health and Social Care in 2022, the New Hospital Programme in the United Kingdom will set up 48 new hospitals by 2030. Additionally, the hospital is the primary user of in-vitro devices and is expected to have a significant impact on the demand for in-vitro diagnostics products in the united kingdom
Additionally, the rising geriatric population in the United Kingdom will increase the burden of chronic and infectious diseases, as they are more prone to infections and age-related diseases due to low immunogenicity. For instance, according to data from The World Bank, the population of 65 years and over was almost 12.7 million in 2021, an increase of 1.4% compared to the previous year. This is further anticipated to increase the demand and adoption of IVD devices and is expected to drive the growth of the in-vitro diagnostics market in the country shortly.
Thus, the increasing prevalence of chronic diseases, rising investment for advancing healthcare infrastructure, and growing geriatric population in the United Kingdom are anticipated to increase the demand and adoption of IVD devices and foster market growth.
Europe In Vitro Diagnostics (IVD) Industry Overview
The European in-vitro diagnostics market is highly competitive due to the many market players in the region. The major market players in Europe are focusing on partnerships, agreements, and product launches to enhance their market presence. Some of the key players in the market include Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific Inc., among others. However, with the help of product innovation and technological advancements, new players can enter the market.
Europe In Vitro Diagnostics (IVD) Market Leaders
-
Sysmex Corporation
-
QIAGEN
-
BioMérieux SA
-
F. Hoffmann-La Roche Ltd
-
Illumina, Inc.
*Disclaimer: Major Players sorted in no particular order
Europe In Vitro Diagnostics (IVD) Market News
- In March 2023, MGI Tech Co., Ltd. received the CE mark for the DNBSeq-G99 sequencer with an aim to precise sequencing of genetic substances.
- In December 2022, BioMérieux SA received the CE mark for Vidas Kube automated immunoassay system to diagnose immunochemistry, infectious diseases, and food industry pathogens.
- In September 2022, Noul Co., Ltd. received the CE-IVD mark for two next-generation diagnostic testing products, miLab Cartridge CER and miLab Cartridge BCM to expand its product line in in-vitro diagnostics systems.
Europe In Vitro Diagnostics (IVD) Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Increasing Demand for Point-of-care Diagnostics
4.2.3 Technological Advancements in In-Vitro Diagnostics Devices
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Cumbersome Reimbursement Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Hematology
5.1.4 Immuno Diagnostics
5.1.5 Other Test Types
5.2 By Product
5.2.1 Instrument
5.2.2 Reagents
5.2.3 Other Products
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Autoimmune Disease
5.4.6 Nephrology
5.4.7 Other Applications
5.5 By End User
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals and Clinics
5.5.3 Other End Users
5.6 Geography
5.6.1 Germany
5.6.2 United Kingdom
5.6.3 France
5.6.4 Italy
5.6.5 Spain
5.6.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Danaher Corporation (Beckman Coulter, Inc)
6.1.5 Hologic, Inc.
6.1.6 Roche Diagnostics
6.1.7 Siemens Healthcare
6.1.8 Thermo Fisher Scientific Inc.
6.1.9 Sysmex Corporation
6.1.10 QIAGEN
6.1.11 BioMerieux SA
6.1.12 Tesa SE
6.1.13 Diasorin S.p.A
6.1.14 Illumina, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Europe In Vitro Diagnostics (IVD) Industry Segmentation
As per the scope of this report, in-vitro diagnostics are the tests performed in laboratories or by consumers at home to diagnose, monitor, screen, and assess various diseases, conditions, or infections. IVD products are reagents, instruments, and systems intended for use in diagnosing diseases or other conditions. IVDs form an essential part of the current healthcare system. They reduce hospital stays and the need to recuperate. The Europe In-Vitro Diagnostics Market is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users) and Geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.
| By Test Type | |
| Clinical Chemistry | |
| Molecular Diagnostics | |
| Hematology | |
| Immuno Diagnostics | |
| Other Test Types |
| By Product | |
| Instrument | |
| Reagents | |
| Other Products |
| By Usability | |
| Disposable IVD Devices | |
| Reusable IVD Devices |
| By Application | |
| Infectious Disease | |
| Diabetes | |
| Cancer/Oncology | |
| Cardiology | |
| Autoimmune Disease | |
| Nephrology | |
| Other Applications |
| By End User | |
| Diagnostic Laboratories | |
| Hospitals and Clinics | |
| Other End Users |
| Geography | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe In Vitro Diagnostics (IVD) Market Research FAQs
What is the current Europe In-Vitro Diagnostics Market size?
The Europe In-Vitro Diagnostics Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in Europe In-Vitro Diagnostics Market?
Sysmex Corporation, QIAGEN, BioMérieux SA, F. Hoffmann-La Roche Ltd and Illumina, Inc. are the major companies operating in the Europe In-Vitro Diagnostics Market.
What years does this Europe In-Vitro Diagnostics Market cover?
The report covers the Europe In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe IVD Industry Report
The Europe In Vitro Diagnostics (IVD) market is segmented by test type, product, usability, application, end user, and geography. The market analysis includes clinical chemistry, molecular diagnostics, immuno diagnostics, hematology, and other test types. The market overview highlights the significance of instruments, reagents, and other products, with a focus on disposable and reusable IVD devices. Applications cover infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and other applications. Key end users include diagnostic laboratories, hospitals and clinics, and other end users.
The market trends indicate a significant growth rate, driven by advancements in molecular diagnostics and immuno diagnostics. The industry analysis reveals that major players are investing in new technologies to enhance market value. The market segmentation by geography includes Germany, United Kingdom, France, Italy, Spain, and the rest of Europe, providing a comprehensive industry outlook.
Industry reports and market research highlight the evolving landscape of the IVD market. The market forecast suggests a positive growth trajectory, supported by increasing demand for accurate and efficient diagnostic tools. The market leaders are focusing on expanding their product portfolios to cater to the diverse needs of the market.
The industry trends indicate a shift towards personalized medicine, which is expected to drive market growth. The market data and industry statistics provide valuable insights into the current market scenario and future predictions. The market review and industry information emphasize the importance of continuous innovation and research to maintain a competitive edge.
The report example includes detailed industry sales and market predictions, offering a thorough market overview. The report pdf is available for download, providing in-depth market analysis and industry research. Research companies are actively contributing to the market by developing advanced diagnostic solutions.
In conclusion, the Europe IVD market is poised for significant growth, with a strong focus on innovation and technological advancements. The market outlook remains positive, with increasing investments in research and development driving the market forward. The industry size and market value are expected to witness substantial growth, supported by favorable market trends and industry statistics.
Europe IVD Market Report Snapshots
